Back to Search Start Over

Development of multicore hybrid particles for drug delivery through the precipitation of CO2 saturated emulsions.

Authors :
Gonçalves VSS
Rodríguez-Rojo S
Matias AA
Nunes AVM
Nogueira ID
Nunes D
Fortunato E
de Matos APA
Cocero MJ
Duarte CMM
Source :
International journal of pharmaceutics [Int J Pharm] 2015 Jan 15; Vol. 478 (1), pp. 9-18. Date of Electronic Publication: 2014 Nov 06.
Publication Year :
2015

Abstract

Hybrid lipid-polymer particles are gaining increasing interest to be applied as drug delivery systems due to their greater stability in biological fluids and enhanced cellular uptake of drugs. However, a major drawback is the fact that these particles are usually produced through techniques that use organic solvents. This work studies the possibility of producing for the first time hybrid particles composed by lipid multicores enveloped in a polymeric layer through Particles from Gas Saturated Solutions (PGSS(®)), without using organic solvents. An oil-in-water emulsion, composed by Gelucire 43/01™ (GEL) as the discontinuous phase and by an aqueous polyethylene glycol 4000 (PEG) solution as the continuous phase, was successfully precipitated by PGSS(®). Operating conditions that ensured the stability of the CO2 saturated emulsion were previously evaluated. The resulting PEG-GEL particles present a spherical-like morphology constituted by several lipid cores encapsulated into a polymeric shell. The applicability of these structured particles to be used as drug delivery system (DDS) was studied by using ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID), as model drug. The particles provided an initial burst release of the drug due to the progressive dissolution of the external layer of PEG, followed by a controlled release of the NSAID from the GEL cores.<br /> (Copyright © 2014. Published by Elsevier B.V.)

Details

Language :
English
ISSN :
1873-3476
Volume :
478
Issue :
1
Database :
MEDLINE
Journal :
International journal of pharmaceutics
Publication Type :
Academic Journal
Accession number :
25445975
Full Text :
https://doi.org/10.1016/j.ijpharm.2014.11.003